Healthcare -
Biotechnology - NASDAQ - US
$ 0.1538
-1.91 %
$ 6.11 M
Market Cap
-0.14
P/E
VIRX - TOTAL EQUITY
Total Equity VIRX - Viracta Therapeutics, Inc.
18.3 M
LAST VALUE
-55.94%
2 YEAR CAGR
35.62%
5 YEAR CAGR
17.37%
10 YEAR CAGR